Search company, investor...

Founded Year

2017

Stage

Series B | Dead

Total Raised

$35M

Last Raised

$35M

About Whisper

Whisper specializes in artificial intelligence and hearing care solutions. The company's main offering was the Whisper Hearing System, a product designed to improve people's ability to hear and engage with sound. However, they have recently shifted their focus away from hearing aids and have stopped supporting this product. It was founded in 2017 and is based in San Francisco, California.

Headquarters Location

260 8th Street

San Francisco, California, 94103,

United States

844-936-4327

Loading...

Loading...

Research containing Whisper

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Whisper in 1 CB Insights research brief, most recently on May 17, 2022.

Expert Collections containing Whisper

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Whisper is included in 2 Expert Collections, including AI 100.

A

AI 100

100 items

A

Artificial Intelligence

6,888 items

Whisper Patents

Whisper has filed 8 patents.

The 3 most popular patent topics include:

  • electronic musical instruments
  • sensors
  • social networking services
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/3/2021

10/8/2024

Container formats, Video codecs, Video hosting, Open formats, Operas

Grant

Application Date

9/3/2021

Grant Date

10/8/2024

Title

Related Topics

Container formats, Video codecs, Video hosting, Open formats, Operas

Status

Grant

Latest Whisper News

AI tool in hospitals creates fake statements, warn researchers

Nov 2, 2024

5 minute read SAN FRANCISCO—Tech behemoth OpenAI has touted its artificial intelligence-powered transcription tool Whisper as having near “human level robustness and accuracy.” But Whisper has a major flaw: It is prone to making up chunks of text or even entire sentences, according to interviews with more than a dozen software engineers, developers and academic researchers. Those experts said some of the invented text—known in the industry as hallucinations—can include racial commentary, violent rhetoric and even imagined medical treatments. Experts said that such fabrications are problematic because Whisper is being used in a slew of industries worldwide to translate and transcribe interviews, generate text in popular consumer technologies and create subtitles for videos. More concerning, they said, is a rush by medical centers to utilize Whisper-based tools to transcribe patients’ consultations with doctors, despite OpenAI’ s warnings that the tool should not be used in “high-risk domains.” The full extent of the problem is difficult to discern, but researchers and engineers said they frequently have come across Whisper’s hallucinations in their work. A University of Michigan researcher conducting a study of public meetings, for example, said he found hallucinations in eight out of every 10 audio transcriptions he inspected, before he started trying to improve the model. A machine learning engineer said he initially discovered hallucinations in about half of the over 100 hours of Whisper transcriptions he analyzed. A third developer said he found hallucinations in nearly every one of the 26,000 transcripts he created with Whisper. The problems persist even in well-recorded, short audio samples. A recent study by computer scientists uncovered 187 hallucinations in more than 13,000 clear audio snippets they examined. That trend would lead to tens of thousands of faulty transcriptions over millions of recordings, researchers said. Such mistakes could have “really grave consequences,” particularly in hospital settings, said Alondra Nelson, who led the White House Office of Science and Technology Policy for the Biden administration until last year. “Nobody wants a misdiagnosis,” said Nelson, a professor at the Institute for Advanced Study in Princeton, New Jersey. “There should be a higher bar.” Whisper also is used to create closed captioning for the Deaf and hard of hearing—a population at particular risk for faulty transcriptions. That’s because the Deaf and hard of hearing have no way of identifying fabrications “hidden amongst all this other text,” said Christian Vogler, who is deaf and directs Gallaudet University’s Technology Access Program. OpenAI urged to address problem The prevalence of such hallucinations has led experts, advocates and former OpenAI employees to call for the federal government to consider AI regulations. At minimum, they said, OpenAI needs to address the flaw. “This seems solvable if the company is willing to prioritize it,” said William Saunders, a San Francisco-based research engineer who quit OpenAI in February over concerns with the company’s direction. “It’s problematic if you put this out there and people are overconfident about what it can do and integrate it into all these other systems.” An OpenAI spokesperson said the company continually studies how to reduce hallucinations and appreciated the researchers’ findings, adding that OpenAI incorporates feedback in model updates. While most developers assume that transcription tools misspell words or make other errors, engineers and researchers said they had never seen another AI-powered transcription tool hallucinate as much as Whisper. Whisper hallucinations The tool is integrated into some versions of OpenAI’s flagship chatbot ChatGPT, and is a built-in offering in Oracle and Microsoft’s cloud computing platforms, which service thousands of companies worldwide. It is also used to transcribe and translate text into multiple languages. In the last month alone, one recent version of Whisper was downloaded over 4.2 million times from open-source AI platform HuggingFace. Sanchit Gandhi, a machine-learning engineer there, said Whisper is the most popular open-source speech recognition model and is built into everything from call centers to voice assistants. Professors Allison Koenecke of Cornell University and Mona Sloane of the University of Virginia examined thousands of short snippets they obtained from TalkBank, a research repository hosted at Carnegie Mellon University. They determined that nearly 40% of the hallucinations were harmful or concerning because the speaker could be misinterpreted or misrepresented. In an example they uncovered, a speaker said, “He, the boy, was going to, I’m not sure exactly, take the umbrella.” But the transcription software added: “He took a big piece of a cross, a teeny, small piece … I’m sure he didn’t have a terror knife so he killed a number of people.” A speaker in another recording described “two other girls and one lady.” Whisper invented extra commentary on race, adding “two other girls and one lady, um, which were Black.” In a third transcription, Whisper invented a non-existent medication called “hyperactivated antibiotics.” Researchers aren’t certain why Whisper and similar tools hallucinate, but software developers said the fabrications tend to occur amid pauses, background sounds or music playing. OpenAI recommended in its online disclosures against using Whisper in “decision-making contexts, where flaws in accuracy can lead to pronounced flaws in outcomes.” Transcribing doctor appointments That warning hasn’t stopped hospitals or medical centers from using speech-to-text models, including Whisper, to transcribe what’s said during doctor’s visits to free up medical providers to spend less time on note-taking or report writing. Over 30,000 clinicians and 40 health systems, including the Mankato Clinic in Minnesota and Children’s Hospital Los Angeles, have started using a Whisper-based tool built by Nabla, which has offices in France and the US. That tool was fine-tuned on medical language to transcribe and summarize patients’ interactions, said Nabla’s chief technology officer Martin Raison. Company officials said they are aware that Whisper can hallucinate and are addressing the problem. It’s impossible to compare Nabla’s AI-generated transcript to the original recording because Nabla’s tool erases the original audio for “data safety reasons,” Raison said. Nabla said the tool has been used to transcribe an estimated 7 million medical visits. Saunders, the former OpenAI engineer, said erasing the original audio could be worrisome if transcripts aren’t double checked or clinicians can’t access the recording to verify they are correct. “You can’t catch errors if you take away the ground truth,” he said. Nabla said that no model is perfect, and that theirs currently requires medical providers to quickly edit and approve transcribed notes, but that could change. Privacy concerns Because patient meetings with their doctors are confidential, it is hard to know how AI-generated transcripts are affecting them. A California state lawmaker, Rebecca Bauer-Kahan, said she took one of her children to the doctor earlier this year, and refused to sign a form the health network provided that sought her permission to share the consultation audio with vendors that included Microsoft Azure, the cloud computing system run by OpenAI’s largest investor. Bauer-Kahan didn’t want such intimate medical conversations being shared with tech companies, she said. “The release was very specific that for-profit companies would have the right to have this,” said Bauer-Kahan, a Democrat who represents part of the San Francisco suburbs in the state Assembly. “I was like ‘absolutely not.’” John Muir Health spokesman Ben Drew said the health system complies with state and federal privacy laws.

Whisper Frequently Asked Questions (FAQ)

  • When was Whisper founded?

    Whisper was founded in 2017.

  • Where is Whisper's headquarters?

    Whisper's headquarters is located at 260 8th Street, San Francisco.

  • What is Whisper's latest funding round?

    Whisper's latest funding round is Series B.

  • How much did Whisper raise?

    Whisper raised a total of $35M.

  • Who are the investors of Whisper?

    Investors of Whisper include Sequoia Capital, First Round Capital, Institutional Venture Partners, Quiet Ventures and Ballistic Ventures.

  • Who are Whisper's competitors?

    Competitors of Whisper include Himalayan Hemp.

Loading...

Compare Whisper to Competitors

H
Himalayan Hemp

Himalayan Hemp is a cooperative focused on the socio-ecological preservation and innovation of indigenous Himalayan hemp. The company offers products such as hemp sanitary pads, clothing, accessories, food and nutrition items, stationery, and raw produce, as well as consulting services in various business areas. Himalayan Hemp primarily serves the sustainable development sector with a focus on organic farming, innovation, and fair economic practices. It is based in Kangra, India.

I
India Hemp & Co

India Hemp & Co specializes in hemp-based nutrition and wellness products within the health and wellness sector. The company offers a range of items including plant-based protein powders, dietary supplements, and hemp seed oil, all designed to provide natural nutrition. India Hemp & Co also caters to pet wellness with products such as hemp-infused oils and treats for cats and dogs. It was founded in 2019 and is based in Bangalore, India.

H
Hemp Foundation

Hemp Foundation is a leading company in the hemp research and manufacturing sector, focusing on providing sustainable hemp products. The company offers a range of products including biodegradable textiles, bio-plastics, and hemp paper, all designed to support a regenerative future for the environment and the economy. Hemp Foundation primarily serves the B2B fashion and apparel industry with its eco-friendly materials. It was founded in 2019 and is based in Faridabad, India.

u
urbanXtracts

urbanXtracts is a boutique cannabis company focusing on a comprehensive seed-to-market ecosystem within the cannabis industry. The company offers services that encompass cannabis cultivation, processing, product development, and marketing, as well as products that include adult-use THC and CBD compliant products. urbanXtracts caters to the cannabis market with a focus on authenticity and quality. It was founded in 2018 and is based in Warwick, New York.

A
Australian Primary Hemp

Australian Primary Hemp is a company focused on the cultivation and processing of hemp within the agricultural sector. They offer a range of hemp-based products, including oils and seeds, that are 100% Australian grown and emphasize sustainable farming and health benefits. The company primarily serves industries looking for sustainable, natural ingredients and those in need of bulk hemp materials. It was founded in 2016 and is based in Geelong, Victoria.

F
Farmtiva

Farmtiva is a cultivator of hemp that also provides hemp farming and distribution support for farmers and other industry participants.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.